Newtyn Management LLC Sells 13,200 Shares of ARCA biopharma, Inc. (NASDAQ:ABIO)

Newtyn Management LLC reduced its holdings in shares of ARCA biopharma, Inc. (NASDAQ:ABIO – Free Report) by 4.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 300,000 shares of the biopharmaceutical company’s stock after selling 13,200 shares during the quarter. Newtyn Management LLC’s […]

Related Keywords

,Charles Schwab Investment Management Inc ,Nasdaq ,Renaissance Technologies ,Newtyn Management ,Securities Exchange Commission ,Virtu Financial ,Free Report ,Street Group ,Schwab Investment Management ,Stock Down ,Get Free Report ,Visit Holdingschannel ,Arca Biopharma ,Nasdaq Abio ,Fabio ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,